Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sequestration puts speed bumps in drug review fast lane
Fierce Pharma
Friday, March 1, 2013 - 12:00pm
tags:
drug reviews, FDA, sequesters
FDA halts pediatric study of Amgen's Sensipar after death
Fierce Pharma
Friday, March 1, 2013 - 12:00pm
tags:
Sensipar, Amgen, FDA, clinical trials, hyperparathyroidism
Novavax Earnings: Here’s Why Investors are Selling Shares Now
Wall St. Cheat Sheet
Friday, March 1, 2013 - 11:58am
tags:
Novavax, earnings
Idenix Reports In-Line 4Q Loss
Yahoo/Zacks
Friday, March 1, 2013 - 11:47am
tags:
earnings, Idenix
Let the sunshine in: New efforts to reveal the ties between doctors and drug firms
The Economist
Friday, March 1, 2013 - 11:46am
tags:
Physician Payment Sunshine Act, physicians
Merck CEO: Big risks in drug research are needed for science breakthroughs, business success
Yahoo/AP
Friday, March 1, 2013 - 11:45am
tags:
Merck, Kenneth Frazier, Pharma CEOs
Should VIVUS Just Forget This Drug?
Motley Fool
Friday, March 1, 2013 - 11:44am
tags:
Vivus, Stendra, erectile dysfunction
Medical Device Recall or Product Enhancement? FDA’s New Draft Guidance Should Be Recalled for Significant Repairs
FDA Law Blog
Friday, March 1, 2013 - 11:31am
tags:
recalls, FDA, devices
Cumberland Pharmaceuticals Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, March 1, 2013 - 11:29am
tags:
earnings, Cumberland
Amarin believes Vascepa well positioned in triglyceride lowering market
Yahoo/Fly on the Wall
Friday, March 1, 2013 - 11:19am
tags:
Vascepa, Amarin
FDA staff say calcitonin salmon cancer risk appears plausible
Reuters
Friday, March 1, 2013 - 11:17am
tags:
FDA, calcitonin salmon, Novartis, Unigene, Upsher-Smith
Amarin Q4 Call Leaves A Fishy Taste In My Mouth
Seeking Alpha
Friday, March 1, 2013 - 11:16am
tags:
earnings, Amarin
How Earnings Point to MAKO Surgical's Evolving Story
Motley Fool
Friday, March 1, 2013 - 11:14am
tags:
earnings, Mako Surgical
Jury awards $7.8 million in punitive damages in Johnson & Johnson implant lawsuit
Yahoo/AP
Friday, March 1, 2013 - 11:14am
tags:
JNJ, hip implants
Merck's HPV Growth Continues
Motley Fool
Friday, March 1, 2013 - 11:13am
tags:
Merck, HPV, Gardasil
Otsuka, Lundbeck Win Approval for Monthly Abilify Shot
Bloomberg
Friday, March 1, 2013 - 11:12am
tags:
schizophrenia, Lundbeck, Otsuka, Abilify, Abilify Maintena
Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Friday, March 1, 2013 - 11:10am
tags:
AbbVie, BT-061, Humira, GLPG0634
GlaxoSmithKline - Against All Odds
Seeking Alpha
Friday, March 1, 2013 - 11:09am
tags:
GSK
Do We Really Need Head-To-Head Comparison Trials With Statins To Improve Cardiac Health?
Forbes
Friday, March 1, 2013 - 11:06am
tags:
statins
BIO, PhRMA Blast FDA Draft Guidance on E-Subs for Trial Site Data
Outsourcing Pharma
Thursday, February 28, 2013 - 11:44am
tags:
PhRMA, FDA, BIO, clinical trials

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.